Hernandez E - Search Results

1

Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function.

Huerta A, Mérida E, Medina L, Fernandez M, Gutierrez E, Hernandez E, López-Sánchez P, Sevillano A, Portolés J, Trimarchi H, Praga M. Huerta A, et al. Among authors: hernandez e. Clin Kidney J. 2021 Dec 4;15(4):771-777. doi: 10.1093/ckj/sfab244. eCollection 2022 Apr. Clin Kidney J. 2021. PMID: 35371455 Free PMC article.

2

Multiple kidney cysts in thin basement membrane disease with proteinuria and kidney function impairment.

Sevillano AM, Gutierrez E, Morales E, Hernandez E, Molina M, Gonzalez E, Praga M. Sevillano AM, et al. Among authors: hernandez e. Clin Kidney J. 2014 Jun;7(3):251-6. doi: 10.1093/ckj/sfu033. Epub 2014 Apr 15. Clin Kidney J. 2014. PMID: 25852885 Free PMC article.

3

Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy.

Torres A, Domínguez-Gil B, Carreño A, Hernández E, Morales E, Segura J, González E, Praga M. Torres A, et al. Among authors: hernandez e. Kidney Int. 2002 Jan;61(1):219-27. doi: 10.1046/j.1523-1755.2002.00124.x. Kidney Int. 2002. PMID: 11786104 Free article.

4

Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney.

González E, Gutiérrez E, Morales E, Hernández E, Andres A, Bello I, Díaz-González R, Leiva O, Praga M. González E, et al. Among authors: hernandez e. Kidney Int. 2005 Jul;68(1):263-70. doi: 10.1111/j.1523-1755.2005.00401.x. Kidney Int. 2005. PMID: 15954916 Free article.

5

Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy.

Gutiérrez E, González E, Hernández E, Morales E, Martínez MA, Usera G, Praga M. Gutiérrez E, et al. Among authors: hernandez e. Clin J Am Soc Nephrol. 2007 Jan;2(1):51-7. doi: 10.2215/CJN.02670706. Epub 2006 Nov 29. Clin J Am Soc Nephrol. 2007. PMID: 17699387

6

Gastrointestinal complications induced by sevelamer crystals.

Yuste C, Mérida E, Hernández E, García-Santiago A, Rodríguez Y, Muñoz T, Gómez GJ, Sevillano Á, Praga M. Yuste C, et al. Among authors: hernandez e. Clin Kidney J. 2017 Aug;10(4):539-544. doi: 10.1093/ckj/sfx013. Epub 2017 Apr 10. Clin Kidney J. 2017. PMID: 28852493 Free PMC article.

7

Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies.

Morales E, Valero MA, León M, Hernández E, Praga M. Morales E, et al. Among authors: hernandez e. Am J Kidney Dis. 2003 Feb;41(2):319-27. doi: 10.1053/ajkd.2003.50039. Am J Kidney Dis. 2003. PMID: 12552492 Clinical Trial.

8

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.

Praga M, Gutiérrez E, González E, Morales E, Hernández E. Praga M, et al. Among authors: hernandez e. J Am Soc Nephrol. 2003 Jun;14(6):1578-83. doi: 10.1097/01.asn.0000068460.37369.dc. J Am Soc Nephrol. 2003. PMID: 12761258 Clinical Trial.

9

Calciphylaxis: Beyond CKD-MBD.

Fernández M, Morales E, Gutierrez E, Polanco N, Hernández E, Mérida E, Praga M. Fernández M, et al. Among authors: hernandez e. Nefrologia. 2017 Sep-Oct;37(5):501-507. doi: 10.1016/j.nefro.2017.02.006. Epub 2017 Apr 5. Nefrologia. 2017. PMID: 28390776 Free article. English, Spanish.

10

Elevation of von Willebrand factor levels in patients with IgA nephropathy: effect of ACE inhibition.

Hernández E, Toledo T, Alamo C, Mon C, Rodicio JL, Praga M. Hernández E, et al. Am J Kidney Dis. 1997 Sep;30(3):397-403. doi: 10.1016/s0272-6386(97)90285-7. Am J Kidney Dis. 1997. PMID: 9292569

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,908 results

Search Page

Filters